Highlights

array(40) {
  [0]=>
  string(4) "2354"
  ["article_id"]=>
  string(4) "2354"
  [1]=>
  string(93) "&#nlEuropean Immunization Week 2019: statement by Executive Director Guido Rasi, , 24/04/2019"
  ["article_title"]=>
  string(93) "&#nlEuropean Immunization Week 2019: statement by Executive Director Guido Rasi, , 24/04/2019"
  [2]=>
  string(170) "&#nl&#nl          &#nl              &#nl&#nlVaccine-preventable diseases are making a comeback in Europe. Let’s take the example of measles, a potentially deadly d"
  ["short_description"]=>
  string(170) "&#nl&#nl          &#nl              &#nl&#nlVaccine-preventable diseases are making a comeback in Europe. Let’s take the example of measles, a potentially deadly d"
  [3]=>
  string(203) "&#nl&#nl          &#nl              &#nl&#nlVaccine-preventable diseases are making a comeback in Europe. Let’s take the example of measles, a potentially deadly disease. From July 2017 to June..."
  ["description"]=>
  string(203) "&#nl&#nl          &#nl              &#nl&#nlVaccine-preventable diseases are making a comeback in Europe. Let’s take the example of measles, a potentially deadly disease. From July 2017 to June..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "88"
  ["rss_id"]=>
  string(2) "88"
  [14]=>
  string(106) "
https://www.ema.europa.eu/en/news/european-immunization-week-2019-statement-executive-director-guido-rasi"
  ["blog_url"]=>
  string(106) "
https://www.ema.europa.eu/en/news/european-immunization-week-2019-statement-executive-director-guido-rasi"
  [15]=>
  string(19) "2019-04-24 23:40:00"
  ["add_date"]=>
  string(19) "2019-04-24 23:40:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:42:13"
  ["create_at"]=>
  string(19) "2019-05-09 16:42:13"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

&#nlEuropean Immunization Week 2019: statement by Executive Director Guido Rasi, , 24/04/2

&#nl&#nl &#nl &#nl&#nlVaccine-preventable diseases are making a comeback in Europe. Let’s t

array(40) {
  [0]=>
  string(4) "2426"
  ["article_id"]=>
  string(4) "2426"
  [1]=>
  string(68) "Infant death in trial yet Novartis anticipates no threat to approval"
  ["article_title"]=>
  string(68) "Infant death in trial yet Novartis anticipates no threat to approval"
  [2]=>
  string(150) "Novartis investigates the death of an infant in a gene therapy clinical trial to determine whether it was related to the treatment but does not antici"
  ["short_description"]=>
  string(150) "Novartis investigates the death of an infant in a gene therapy clinical trial to determine whether it was related to the treatment but does not antici"
  [3]=>
  string(181) "Novartis investigates the death of an infant in a gene therapy clinical trial to determine whether it was related to the treatment but does not anticipate an impact on FDA approval."
  ["description"]=>
  string(181) "Novartis investigates the death of an infant in a gene therapy clinical trial to determine whether it was related to the treatment but does not anticipate an impact on FDA approval."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(3) "107"
  ["rss_id"]=>
  string(3) "107"
  [14]=>
  string(147) "https://www.biopharma-reporter.com/Article/2019/04/24/Novartis-SMA-gene-therapy-awaits-approval?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(147) "https://www.biopharma-reporter.com/Article/2019/04/24/Novartis-SMA-gene-therapy-awaits-approval?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2019-04-24 23:04:00"
  ["add_date"]=>
  string(19) "2019-04-24 23:04:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:42:36"
  ["create_at"]=>
  string(19) "2019-05-09 16:42:36"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Infant death in trial yet Novartis anticipates no threat to approval

Novartis investigates the death of an infant in a gene therapy clinical trial to determine whether it was related to the

array(40) {
  [0]=>
  string(4) "2427"
  ["article_id"]=>
  string(4) "2427"
  [1]=>
  string(63) "AbbVie gets nod for psoriasis drug ahead of Humira patent cliff"
  ["article_title"]=>
  string(63) "AbbVie gets nod for psoriasis drug ahead of Humira patent cliff"
  [2]=>
  string(152) "AbbVie receives approval from the US FDA for its newest psoriasis drug, Skyrizi, which looks set to recoup some of Humiraâs revenue when it loses pat"
  ["short_description"]=>
  string(152) "AbbVie receives approval from the US FDA for its newest psoriasis drug, Skyrizi, which looks set to recoup some of Humiraâs revenue when it loses pat"
  [3]=>
  string(167) "AbbVie receives approval from the US FDA for its newest psoriasis drug, Skyrizi, which looks set to recoup some of Humiraâs revenue when it loses patent protection."
  ["description"]=>
  string(167) "AbbVie receives approval from the US FDA for its newest psoriasis drug, Skyrizi, which looks set to recoup some of Humiraâs revenue when it loses patent protection."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(3) "107"
  ["rss_id"]=>
  string(3) "107"
  [14]=>
  string(149) "https://www.biopharma-reporter.com/Article/2019/04/24/AbbVie-receives-approval-for-psoriasis-drug?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(149) "https://www.biopharma-reporter.com/Article/2019/04/24/AbbVie-receives-approval-for-psoriasis-drug?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2019-04-24 21:42:00"
  ["add_date"]=>
  string(19) "2019-04-24 21:42:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:42:36"
  ["create_at"]=>
  string(19) "2019-05-09 16:42:36"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

AbbVie gets nod for psoriasis drug ahead of Humira patent cliff

AbbVie receives approval from the US FDA for its newest psoriasis drug, Skyrizi, which looks set to recoup some of Humir

array(40) {
  [0]=>
  string(4) "2170"
  ["article_id"]=>
  string(4) "2170"
  [1]=>
  string(61) "Laser Wire Solutions wins Queen’s Award for Innovation"
  ["article_title"]=>
  string(61) "Laser Wire Solutions wins Queen’s Award for Innovation"
  [2]=>
  string(155) "Laser Wire Solutions has been awarded the Queen’s Award for Innovation for its pinpoint accurate technology which was developed to help the manufact"
  ["short_description"]=>
  string(155) "Laser Wire Solutions has been awarded the Queen’s Award for Innovation for its pinpoint accurate technology which was developed to help the manufact"
  [3]=>
  string(178) "Laser Wire Solutions has been awarded the Queen’s Award for Innovation for its pinpoint accurate technology which was developed to help the manufacture of medical devices."
  ["description"]=>
  string(178) "Laser Wire Solutions has been awarded the Queen’s Award for Innovation for its pinpoint accurate technology which was developed to help the manufacture of medical devices."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(103) "https://www.medicalplasticsnews.com/news/queen%E2%80%99s-award-for-innovation-for-laser-wire-solutions/"
  ["blog_url"]=>
  string(103) "https://www.medicalplasticsnews.com/news/queen%E2%80%99s-award-for-innovation-for-laser-wire-solutions/"
  [15]=>
  string(19) "2019-04-24 19:25:59"
  ["add_date"]=>
  string(19) "2019-04-24 19:25:59"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:40"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:40"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Laser Wire Solutions wins Queen’s Award for Innovation

Laser Wire Solutions has been awarded the Queen’s Award for Innovation for its pinpoint accurate technology which

array(40) {
  [0]=>
  string(4) "2171"
  ["article_id"]=>
  string(4) "2171"
  [1]=>
  string(87) "Protolabs announces collaboration with Cleveland Clinic Healthcare Innovations Alliance"
  ["article_title"]=>
  string(87) "Protolabs announces collaboration with Cleveland Clinic Healthcare Innovations Alliance"
  [2]=>
  string(152) "Protolabs are collaborating with the Cleveland Clinic Healthcare Innovations Alliance on an awards programme which aims to drive novel healthcare ide"
  ["short_description"]=>
  string(152) "Protolabs are collaborating with the Cleveland Clinic Healthcare Innovations Alliance on an awards programme which aims to drive novel healthcare ide"
  [3]=>
  string(193) "Protolabs are collaborating with the Cleveland Clinic Healthcare Innovations Alliance on an awards programme which aims to drive novel healthcare ideas in to real-world products and devices."
  ["description"]=>
  string(193) "Protolabs are collaborating with the Cleveland Clinic Healthcare Innovations Alliance on an awards programme which aims to drive novel healthcare ideas in to real-world products and devices."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(115) "https://www.medicalplasticsnews.com/mpn-north-america/protolabs-announces-collaboration-with-cleveland-clinic-heal/"
  ["blog_url"]=>
  string(115) "https://www.medicalplasticsnews.com/mpn-north-america/protolabs-announces-collaboration-with-cleveland-clinic-heal/"
  [15]=>
  string(19) "2019-04-24 17:15:05"
  ["add_date"]=>
  string(19) "2019-04-24 17:15:05"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:40"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:40"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Protolabs announces collaboration with Cleveland Clinic Healthcare Innovations Alliance

Protolabs are collaborating with the Cleveland Clinic Healthcare Innovations Alliance on an awards programme which ai

array(40) {
  [0]=>
  string(4) "5617"
  ["article_id"]=>
  string(4) "5617"
  [1]=>
  string(63) "Scholars International Conference on Pediatrics and Neonatology"
  ["article_title"]=>
  string(63) "Scholars International Conference on Pediatrics and Neonatology"
  [2]=>
  string(158) "Scholars Conferences is proud to present the highly anticipated “Scholars International Conference on Pediatrics and Neonatology” (Pediatrics Scho"
  ["short_description"]=>
  string(158) "Scholars Conferences is proud to present the highly anticipated “Scholars International Conference on Pediatrics and Neonatology” (Pediatrics Scho"
  [3]=>
  string(449) "Scholars Conferences is proud to present the highly anticipated “Scholars International Conference on Pediatrics and Neonatology” (Pediatrics Scholars 2019) to be held on December 02-03, 2019 at Madrid, Spain. The conference programme consists of world-class keynote addresses, industry-led presentations, as well as extensive networking opportunities, creating an interactive platform for high-level scientific and business discussions."
  ["description"]=>
  string(449) "Scholars Conferences is proud to present the highly anticipated “Scholars International Conference on Pediatrics and Neonatology” (Pediatrics Scholars 2019) to be held on December 02-03, 2019 at Madrid, Spain. The conference programme consists of world-class keynote addresses, industry-led presentations, as well as extensive networking opportunities, creating an interactive platform for high-level scientific and business discussions."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(95) "https://www.pharmiweb.com/event/scholars-international-conference-on-pediatrics-and-neonatology"
  ["blog_url"]=>
  string(95) "https://www.pharmiweb.com/event/scholars-international-conference-on-pediatrics-and-neonatology"
  [15]=>
  string(19) "2019-04-24 11:51:57"
  ["add_date"]=>
  string(19) "2019-04-24 11:51:57"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-11-06 14:38:59"
  ["create_at"]=>
  string(19) "2019-11-06 14:38:59"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Scholars International Conference on Pediatrics and Neonatology

Scholars Conferences is proud to present the highly anticipated “Scholars International Conference on Pediatrics a

array(40) {
  [0]=>
  string(4) "2172"
  ["article_id"]=>
  string(4) "2172"
  [1]=>
  string(61) "Meet at Med-Tech Innovation Expo: Oliver Healthcare Packaging"
  ["article_title"]=>
  string(61) "Meet at Med-Tech Innovation Expo: Oliver Healthcare Packaging"
  [2]=>
  string(123) "Oliver Healthcare Packaging is inviting visitors to learn more about CleanCut Technologies at the Med-Tech Innovation Expo."
  ["short_description"]=>
  string(123) "Oliver Healthcare Packaging is inviting visitors to learn more about CleanCut Technologies at the Med-Tech Innovation Expo."
  [3]=>
  string(123) "Oliver Healthcare Packaging is inviting visitors to learn more about CleanCut Technologies at the Med-Tech Innovation Expo."
  ["description"]=>
  string(123) "Oliver Healthcare Packaging is inviting visitors to learn more about CleanCut Technologies at the Med-Tech Innovation Expo."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(102) "https://www.medicalplasticsnews.com/news/meet-at-med-tech-innovation-expo-oliver-healthcare-packaging/"
  ["blog_url"]=>
  string(102) "https://www.medicalplasticsnews.com/news/meet-at-med-tech-innovation-expo-oliver-healthcare-packaging/"
  [15]=>
  string(19) "2019-04-23 23:00:00"
  ["add_date"]=>
  string(19) "2019-04-23 23:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:40"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:40"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Meet at Med-Tech Innovation Expo: Oliver Healthcare Packaging

Oliver Healthcare Packaging is inviting visitors to learn more about CleanCut Technologies at the Med-Tech Innovation Ex

array(40) {
  [0]=>
  string(4) "2352"
  ["article_id"]=>
  string(4) "2352"
  [1]=>
  string(139) "Perforce Software: Medical Device Industry Survey Reveals 75% Satisfaction With Hybrid Development Method, Lowered Confidence in Compliance"
  ["article_title"]=>
  string(139) "Perforce Software: Medical Device Industry Survey Reveals 75% Satisfaction With Hybrid Development Method, Lowered Confidence in Compliance"
  [2]=>
  string(150) "Survey of 270 professionals shows only 38% “Very confident” they could pass a surprise audit; productivity and visibility challenges from "
  ["short_description"]=>
  string(150) "Survey of 270 professionals shows only 38% “Very confident” they could pass a surprise audit; productivity and visibility challenges from "
  [3]=>
  string(599) "Survey of 270 professionals shows only 38% “Very confident” they could pass a surprise audit; productivity and visibility challenges from manual development processes also raisedMINNEAPOLIS, MN, April 23, 2019 — Perforce Software, a provider of solutions to enterprise teams requiring productivity, visibility, security, and scale along the development lifecycle, released the results of a global survey of medical device professionals today. Key findings suggest ongoing struggles with manual development, a trend-bucking shift toward hybrid development...&#nl&#nlSource: RealWire"
  ["description"]=>
  string(599) "Survey of 270 professionals shows only 38% “Very confident” they could pass a surprise audit; productivity and visibility challenges from manual development processes also raisedMINNEAPOLIS, MN, April 23, 2019 — Perforce Software, a provider of solutions to enterprise teams requiring productivity, visibility, security, and scale along the development lifecycle, released the results of a global survey of medical device professionals today. Key findings suggest ongoing struggles with manual development, a trend-bucking shift toward hybrid development...&#nl&#nlSource: RealWire"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "64"
  ["rss_id"]=>
  string(2) "64"
  [14]=>
  string(87) "http://www.realwire.com/releases/Medical-Device-Industry-Survey-Reveals-75-Satisfaction"
  ["blog_url"]=>
  string(87) "http://www.realwire.com/releases/Medical-Device-Industry-Survey-Reveals-75-Satisfaction"
  [15]=>
  string(19) "2019-04-23 21:16:00"
  ["add_date"]=>
  string(19) "2019-04-23 21:16:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:42:04"
  ["create_at"]=>
  string(19) "2019-05-09 16:42:04"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Perforce Software: Medical Device Industry Survey Reveals 75% Satisfaction With Hybrid Dev

Survey of 270 professionals shows only 38% “Very confident” they could pass a surprise audit; productivity a

array(40) {
  [0]=>
  string(4) "2173"
  ["article_id"]=>
  string(4) "2173"
  [1]=>
  string(81) "The small print: A 3D bioprinter is now present in Queen's University Belfast"
  ["article_title"]=>
  string(81) "The small print: A 3D bioprinter is now present in Queen's University Belfast"
  [2]=>
  string(153) "Queen's University Belfast has invested in a 3D bioprinter from GeSiM for research into the manufacture of medical devices and drug delivery systems."
  ["short_description"]=>
  string(153) "Queen's University Belfast has invested in a 3D bioprinter from GeSiM for research into the manufacture of medical devices and drug delivery systems."
  [3]=>
  string(153) "Queen's University Belfast has invested in a 3D bioprinter from GeSiM for research into the manufacture of medical devices and drug delivery systems."
  ["description"]=>
  string(153) "Queen's University Belfast has invested in a 3D bioprinter from GeSiM for research into the manufacture of medical devices and drug delivery systems."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(57) "https://www.medicalplasticsnews.com/news/the-small-print/"
  ["blog_url"]=>
  string(57) "https://www.medicalplasticsnews.com/news/the-small-print/"
  [15]=>
  string(19) "2019-04-23 18:23:28"
  ["add_date"]=>
  string(19) "2019-04-23 18:23:28"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:40"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:40"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

The small print: A 3D bioprinter is now present in Queen's University Belfast

Queen's University Belfast has invested in a 3D bioprinter from GeSiM for research into the manufacture of medical d

array(40) {
  [0]=>
  string(4) "2174"
  ["article_id"]=>
  string(4) "2174"
  [1]=>
  string(71) "Are plastics that are used within the healthcare sector being recycled?"
  ["article_title"]=>
  string(71) "Are plastics that are used within the healthcare sector being recycled?"
  [2]=>
  string(152) "Ole Grøndahl Hansen, project manager of PVCMed Alliance, discusses how plastics have paved the way for significantly longer lives, and why recycling "
  ["short_description"]=>
  string(152) "Ole Grøndahl Hansen, project manager of PVCMed Alliance, discusses how plastics have paved the way for significantly longer lives, and why recycling "
  [3]=>
  string(194) "Ole Grøndahl Hansen, project manager of PVCMed Alliance, discusses how plastics have paved the way for significantly longer lives, and why recycling is key for medical plastics in the future."
  ["description"]=>
  string(194) "Ole Grøndahl Hansen, project manager of PVCMed Alliance, discusses how plastics have paved the way for significantly longer lives, and why recycling is key for medical plastics in the future."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(69) "https://www.medicalplasticsnews.com/news/the-importance-of-recycling/"
  ["blog_url"]=>
  string(69) "https://www.medicalplasticsnews.com/news/the-importance-of-recycling/"
  [15]=>
  string(19) "2019-04-23 18:00:09"
  ["add_date"]=>
  string(19) "2019-04-23 18:00:09"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:40"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:40"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Are plastics that are used within the healthcare sector being recycled?

Ole Grøndahl Hansen, project manager of PVCMed Alliance, discusses how plastics have paved the way for significantly

array(40) {
  [0]=>
  string(4) "2175"
  ["article_id"]=>
  string(4) "2175"
  [1]=>
  string(88) "Road to recovery: Why manufacturers need to ensure their processes meet agreed protocols"
  ["article_title"]=>
  string(88) "Road to recovery: Why manufacturers need to ensure their processes meet agreed protocols"
  [2]=>
  string(150) "Lucy Pamment, a supply chain technology specialist for Access Group, believes the recent Implant Files scandal will put further pressure on medical de"
  ["short_description"]=>
  string(150) "Lucy Pamment, a supply chain technology specialist for Access Group, believes the recent Implant Files scandal will put further pressure on medical de"
  [3]=>
  string(212) "Lucy Pamment, a supply chain technology specialist for Access Group, believes the recent Implant Files scandal will put further pressure on medical device manufacturers to build transparency into their processes."
  ["description"]=>
  string(212) "Lucy Pamment, a supply chain technology specialist for Access Group, believes the recent Implant Files scandal will put further pressure on medical device manufacturers to build transparency into their processes."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(58) "https://www.medicalplasticsnews.com/news/road-to-recovery/"
  ["blog_url"]=>
  string(58) "https://www.medicalplasticsnews.com/news/road-to-recovery/"
  [15]=>
  string(19) "2019-04-23 17:21:33"
  ["add_date"]=>
  string(19) "2019-04-23 17:21:33"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:40"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:40"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Road to recovery: Why manufacturers need to ensure their processes meet agreed protocols

Lucy Pamment, a supply chain technology specialist for Access Group, believes the recent Implant Files scandal will put

array(40) {
  [0]=>
  string(4) "1927"
  ["article_id"]=>
  string(4) "1927"
  [1]=>
  string(80) "FDA Approves Skyrizi (risankizumab-rzaa) for Moderate to Severe Plaque Psoriasis"
  ["article_title"]=>
  string(80) "FDA Approves Skyrizi (risankizumab-rzaa) for Moderate to Severe Plaque Psoriasis"
  [2]=>
  string(150) "NORTH CHICAGO, Ill., April 23, 2019 /PRNewswire/ -- AbbVie today announced that the U.S. Food and Drug Administration (FDA) approved Skyrizi (risankiz"
  ["short_description"]=>
  string(150) "NORTH CHICAGO, Ill., April 23, 2019 /PRNewswire/ -- AbbVie today announced that the U.S. Food and Drug Administration (FDA) approved Skyrizi (risankiz"
  [3]=>
  string(248) "NORTH CHICAGO, Ill., April 23, 2019 /PRNewswire/ -- AbbVie today announced that the U.S. Food and Drug Administration (FDA) approved Skyrizi (risankizumab-rzaa), an interleukin-23 (IL-23) inhibitor, for the treatment of moderate to severe plaque..."
  ["description"]=>
  string(248) "NORTH CHICAGO, Ill., April 23, 2019 /PRNewswire/ -- AbbVie today announced that the U.S. Food and Drug Administration (FDA) approved Skyrizi (risankizumab-rzaa), an interleukin-23 (IL-23) inhibitor, for the treatment of moderate to severe plaque..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "8"
  ["rss_id"]=>
  string(1) "8"
  [14]=>
  string(240) "https://www.drugs.com/newdrugs/fda-approves-skyrizi-risankizumab-rzaa-moderate-severe-plaque-psoriasis-4951.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Approves+Skyrizi+%28risankizumab-rzaa%29+for+Moderate+to+Severe+Plaque+Psoriasis"
  ["blog_url"]=>
  string(240) "https://www.drugs.com/newdrugs/fda-approves-skyrizi-risankizumab-rzaa-moderate-severe-plaque-psoriasis-4951.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Approves+Skyrizi+%28risankizumab-rzaa%29+for+Moderate+to+Severe+Plaque+Psoriasis"
  [15]=>
  string(19) "2019-04-23 13:04:33"
  ["add_date"]=>
  string(19) "2019-04-23 13:04:33"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:51"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:51"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

FDA Approves Skyrizi (risankizumab-rzaa) for Moderate to Severe Plaque Psoriasis

NORTH CHICAGO, Ill., April 23, 2019 /PRNewswire/ -- AbbVie today announced that the U.S. Food and Drug Administration (F